Treatment combo nearly doubles survival time in some lung cancer patients, study finds

New research just published in the New England Journal of Medicine tells of study results that show doubled survival time for some lung cancer patients who were treated with a combination of chemotherapy and immunotherapy compared to those treated only with chemotherapy, reports Susan Scutti for CNN.

The study included 616 non-squamous non-small cell lung cancer patients, 400 of whom received the combination treatment.

Dr. Jorge Gomez told CNN, “It’s already been 21 months [since the study]. The differences are big enough now that you know it’s going to be a very big number and it’s important to get this information to people so they can start using this regimen.”

This entry was posted in Health Issues. Bookmark the permalink.